nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases
|
Schultze, Anna |
|
|
42 |
12 |
p. 3039-3048 |
artikel |
2 |
A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults
|
Cummings, J.F. |
|
|
42 |
12 |
p. 3066-3074 |
artikel |
3 |
Cost-effectiveness of an in-development adult-formulated 21-valent pneumococcal conjugate vaccine in US adults aged 50 years or older
|
Altawalbeh, Shoroq M. |
|
|
42 |
12 |
p. 3024-3032 |
artikel |
4 |
COVID-19 vaccine uptake among non-US-born populations in the United States, 2020–2022
|
Nolan, Margaret B. |
|
|
42 |
12 |
p. 3115-3121 |
artikel |
5 |
Dendritic cell targeting peptide plus Salmonella FliCd flagellin fused outer membrane protein H (OmpH) demonstrated increased efficacy against infections caused by different Pasteurella multocida serogroups in mouse models
|
Wang, Zihao |
|
|
42 |
12 |
p. 3075-3083 |
artikel |
6 |
Despite mandated primary series, health care personnel still hesitant about COVID-19 vaccine and immunizing children
|
Kainth, Mundeep K. |
|
|
42 |
12 |
p. 3122-3133 |
artikel |
7 |
Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trial
|
Baum, Holly E. |
|
|
42 |
12 |
p. 2945-2950 |
artikel |
8 |
Early use of oral cholera vaccines as a prime control measure during outbreaks: Necessary but not sufficient
|
El Bushra, Hassan E. |
|
|
42 |
12 |
p. 3033-3038 |
artikel |
9 |
Editorial Board
|
|
|
|
42 |
12 |
p. ii |
artikel |
10 |
Effectiveness of COVID-19 vaccination against school absenteeism in children and adolescents hospitalized with COVID-19
|
Maltezou, Helena C. |
|
|
42 |
12 |
p. 2941-2944 |
artikel |
11 |
Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistance
|
Grant, Lindsay R. |
|
|
42 |
12 |
p. 2983-2993 |
artikel |
12 |
Heritability and genome-wide association study of vaccine-induced immune response in Beagles: A pilot study
|
Blake, Jeanna M. |
|
|
42 |
12 |
p. 3099-3106 |
artikel |
13 |
Immunogenicity and safety of adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)-Haemophilus type b conjugate combined vaccine (DPT-IPV-Hib) in healthy Japanese Infants ≥ 2 and < 43 months of Age: A phase III, multicenter, active controlled, assessor-blinded, randomized, parallel-group study
|
Nakano, Takashi |
|
|
42 |
12 |
p. 3134-3143 |
artikel |
14 |
Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults: A phase 3, randomized, active-controlled, multicenter trial
|
Nurdin, Asrawati |
|
|
42 |
12 |
p. 3009-3017 |
artikel |
15 |
Immunogenicity and safety of Sinovac-CoronaVac booster vaccinations in 12–17- year-olds with clinically significant reactions from Pfizer-BNT162b2 vaccination
|
Chong, Chia-Yin |
|
|
42 |
12 |
p. 2951-2954 |
artikel |
16 |
Indirect vaccine effectiveness in an outbreak of Alpha B.1.1.7 variant in a California state Prison, May 2021
|
Archer, Helena |
|
|
42 |
12 |
p. 3057-3065 |
artikel |
17 |
Is vaccination against measles, mumps, and rubella associated with reduced rates of antibiotic treatments among children below the age of 2 years? Nationwide register-based study from Denmark, Finland, Norway, and Sweden
|
Gehrt, Lise |
|
|
42 |
12 |
p. 2955-2965 |
artikel |
18 |
Minimal interval for the administration of a pneumococcal polysaccharide vaccine following the administration of a pneumococcal conjugate vaccine
|
De Wals, Philippe |
|
|
42 |
12 |
p. 2933-2936 |
artikel |
19 |
Perceptions, attitudes, and willingness of healthcare and frontline workers to participate in an Ebola vaccine trial in Uganda
|
Kimbugwe, Geofrey |
|
|
42 |
12 |
p. 3002-3008 |
artikel |
20 |
Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisation
|
Tembo, G. |
|
|
42 |
12 |
p. 2975-2982 |
artikel |
21 |
Protective effect of PCV13 against all-cause hospitalized pneumonia in children in Beijing, China: real-world evidence
|
Lv, Min |
|
|
42 |
12 |
p. 3091-3098 |
artikel |
22 |
Reliance on sources of immunization information and vaccine uptake among older adults in a rural state: The mediating role of trust
|
Huseth-Zosel, Andrea L. |
|
|
42 |
12 |
p. 3107-3114 |
artikel |
23 |
Retrospective study on the health and economic burden of hospitalized patients due to pneumonia and invasive pneumococcal infections in Belgium settings
|
Magali, Pirson |
|
|
42 |
12 |
p. 3018-3023 |
artikel |
24 |
Safety profile of recombinant adjuvanted anti-herpes zoster vaccine (RZV) in high-risk groups: Data from active surveillance program. Puglia (Italy), 2021–23
|
Stefanizzi, Pasquale |
|
|
42 |
12 |
p. 2966-2974 |
artikel |
25 |
Self-reported determinants of COVID-19 vaccine acceptance among persons with and without autoimmune disease
|
Gong, Jenny D. |
|
|
42 |
12 |
p. 2994-3001 |
artikel |
26 |
The early safety profile of simultaneous vaccination against influenza and Respiratory Syncytial Virus (RSV) in patients with high-risk heart failure
|
Biegus, Jan |
|
|
42 |
12 |
p. 2937-2940 |
artikel |
27 |
Uptake of pneumococcal vaccines in older Australian adults before and after universal public funding of PCV13
|
Binte Hossain, Fariha |
|
|
42 |
12 |
p. 3084-3090 |
artikel |
28 |
Vaccine coverage among children born to immigrant parents in Norway, 2000–2020
|
Nybru Gleditsch, Rebecca |
|
|
42 |
12 |
p. 3049-3056 |
artikel |